ReviewNanomaterials (Basel, Switzerland)2026
Understanding and Exploiting Biological Mechanisms of Radiosensitization Using High Atomic Mass Nanomaterials.
Review in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Radiation therapy is an essential mode of treatment for cancer, but it is limited by resistance, potential damage to healthy tissue, and inefficacy in later-stage cancers. To overcome these limitations, nanoparticles made from high atomic number (Z) atoms, such as silver (AgNPs), gold (AuNPs), and hafnium oxide (HfONPs), have been investigated for their ability to increase radiation dose deposition in cancer cells. Historically, it is believed that radiation dose enhancement primarily is achieved by physical mechanisms like photoelectric and Compton effects. Based upon these mechanisms, the usage of high Z nanoparticles would be expected to have relatively small dose enhancements and a lack of selectivity towards cancer cells under most clinical irradiation conditions. However, high Z nanoparticles exhibit very promising radiosensitizing effects that cannot fully be accounted for by physical effects, suggesting underlying biological interactions with relevant cellular processes caused by the nanoparticles themselves. Specifically, high Z nanoparticles can directly damage proteins and vesicles involved in degradation pathways (e.g., lysosomes and autophagosomes) and induce lipid peroxidation. The observed radiosensitizing effects of high Z nanoparticles may be caused by the sublethal cytotoxic responses of cancer cells to the nanomaterials themselves and are significantly greater than expected, based upon the macroscale physical dose increases in radiation deposition due to the presence of nanomaterials. This review critically analyzes the underlying biological mechanisms that could contribute to the enhancement of radiation effects by these nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.